Increased adenosine triphosphatase in leukocytes of asthmatic children

Insights

Leukocyte adenosine triphosphatase (ATPase) activities are elevated in children with asthma. Glucocorticosteroid therapy and hydrocortisone reduce these elevated ATPase levels, suggesting an enzymatic abnormality in asthma.

Area of Science:

  • Biochemistry
  • Immunology
  • Pediatrics

Background:

  • Asthma is a chronic respiratory condition often associated with immune system dysregulation.
  • Adenosine triphosphatase (ATPase) enzymes play crucial roles in cellular energy metabolism and function.
  • Previous research suggests adrenergic imbalance in asthma, affecting adenylate cyclase responsiveness.

Purpose of the Study:

  • To investigate and compare adenosine triphosphatase (ATPase) activities in leukocytes of asthmatic versus nonasthmatic children.
  • To examine the effect of glucocorticosteroid therapy on leukocyte ATPase activities in asthmatic children.
  • To explore the in vitro effects of hydrocortisone on ATPase activities in normal leukocytes.

Main Methods:

  • Leukocytes were isolated from asthmatic and nonasthmatic children.
  • Adenosine triphosphatase (ATPase) activities (Mg(2+)- and Ca(2+)-dependent) were measured in different leukocyte fractions (membrane and supernatant).
  • Cell surface (ecto) ATPase activity was assessed. In vitro experiments involved incubating normal leukocytes and membranes with hydrocortisone.

Main Results:

  • Significantly elevated Mg(2+)- and Ca(2+)-dependent ATPase activities were observed in membrane and supernatant fractions of asthmatic leukocytes.
  • Intact cell surface ATPase was also significantly elevated in asthmatic leukocytes.
  • Glucocorticosteroid therapy was associated with intermediate ATPase levels, and in vitro hydrocortisone treatment reduced ATPase activities.

Conclusions:

  • Elevated leukocyte ATPase activities are a potential biochemical marker in pediatric asthma.
  • These findings suggest a link between ATPase dysregulation and the known adrenergic imbalance in asthma.
  • The results indicate the possibility of intrinsic enzymatic abnormalities contributing to the asthmatic condition.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...